Home/Filings/4/0001209191-18-060004
4//SEC Filing

Unninayar Kamalam 4

Accession 0001209191-18-060004

CIK 0001123494other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 4:45 PM ET

Size

7.4 KB

Accession

0001209191-18-060004

Insider Transaction Report

Form 4
Period: 2018-11-26
Unninayar Kamalam
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2018-11-26+18,46918,469 total
  • Award

    Stock option (right to buy)

    2018-11-26+44,58544,585 total
    Exercise: $3.79Exp: 2028-11-26Common Stock, par value $0.01 per share (44,585 underlying)
Footnotes (3)
  • [F1]Represents a deferred stock award of restricted stock units which shall vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022.
  • [F2]Includes a deferred stock award of 18,469 restricted stock units which vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022.
  • [F3]This stock option vests in four equal annual installments on November 1, 2019, 2020, 2021 and 2022.

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

Entity typeother

Related Parties

1
  • filerCIK 0001720065

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:45 PM ET
Size
7.4 KB